Cognit is building foundational AI to simulate gene regulatory networks for genomics research, with work focused on cross-cell and cross-species models for high-resolution functional genomics and in-silico gene and cell engineering. Its stated use case is supporting research into complex diseases and decoding gene regulation rather than serving a named commercial customer base. The company describes its approach as generative biology and says it is still at an early research stage, with many models and approaches actively discarded as it learns.